Non-Alcoholic Steatohepatitis Supplement Market Report Scope & Overview:

The Global Non-Alcoholic Steatohepatitis Supplement Market was valued at USD 849.9 Million in 2025 and is expected to reach USD 1,224.3 Million by 2035, growing at a CAGR of 3.7% from 2026 to 2035.

The global Non-Alcoholic Steatohepatitis Supplement Market is growing steadily, driven by increasing awareness of liver health and the rising prevalence of metabolic disorders associated with fatty liver disease. Growing consumer interest in preventive healthcare and nutraceutical-based wellness solutions is supporting demand for supplements containing milk thistle, turmeric, vitamin E, omega-3 fatty acids, probiotics, and other functional ingredients. Increasing adoption of healthier lifestyles and dietary management is further encouraging supplementation. Product innovation and wider availability through pharmacies, health stores, supermarkets, and online platforms are improving accessibility. Additionally, growing research into nutritional approaches for supporting liver function and increasing consumer awareness of NASH and related liver conditions are creating opportunities for market expansion.

The European Liver Patients Association convened the EU NASH Summit in the European Parliament in June 2023 to increase awareness and develop interaction among stakeholders on this public health concern, reflecting sustained regulatory and advocacy attention to NASH as the European region continues bracing for prevalence anticipated to rise by more than 40% by 2030, reinforcing sustained demand for supplement-based management approaches across the region.

Market Size and Forecast:

• Market Size in 2026E: USD 881.5 Million

• Market Size by 2035: USD 1,224.3 Million

• CAGR: 3.7% from 2026 to 2035

• Fastest Growing Region: Europe

• Largest Region: Asia Pacific

To Get More Information On Non-Alcoholic Steatohepatitis Supplement Market - Request Free Sample Report

Non-Alcoholic Steatohepatitis Supplement Market Trends:

• Growing initiatives to promote awareness of NASH continue to encourage patients and healthcare professionals toward supplement-based management approaches.

• Rising research and development investment into NASH-related nutrition is uncovering new candidate ingredients including folate and vitamin B12 combinations.

• Expanding product launches featuring non-GMO, allergen-free supplement formulations are addressing growing consumer preference for clean-label liver support products.

• Increasing physician and consumer education around metabolic dysfunction-associated steatohepatitis is broadening the addressable supplement-using patient population.

• Growing sports nutrition sector entry into liver health supplementation is expanding NASH-adjacent product categories beyond traditional dietary supplement retail channels.

U.S. Non-Alcoholic Steatohepatitis Supplement Market Outlook:

The U.S. Non-Alcoholic Steatohepatitis Supplement Market was valued at USD 84.1 Million in 2025 and is projected to reach USD 143.6 Million by 2035, growing at a CAGR of 5.5% during 2026-2035.

The U.S. Non-Alcoholic Steatohepatitis Supplement Market is growing steadily, driven by increasing awareness of liver health and the rising prevalence of metabolic conditions associated with fatty liver disease. Growing consumer interest in preventive healthcare and nutraceutical solutions is supporting demand for supplements containing milk thistle, turmeric, vitamin E, omega-3 fatty acids, and probiotics. Increasing adoption of healthier diets and active lifestyles is further encouraging supplement use. Product innovation, expanding online availability, and broader distribution through pharmacies, health stores, supermarkets, and specialty retailers are improving consumer access. Additionally, growing awareness of NASH and nutritional approaches to supporting liver health is creating new opportunities for supplement manufacturers in the U.S. market.

Evogen Nutrition, a pioneer in sports nutrition and supplements, introduced a new liver support supplement in 2023 designed to improve liver health and performance, reflecting the sports nutrition sector's continued entry into liver-focused supplementation as manufacturers increasingly recognize crossover demand between athletic performance support and metabolic liver health among health-conscious U.S. consumers.

Non-Alcoholic Steatohepatitis Supplement Market Segment Analysis:

• By Type, Probiotics led the Non-Alcoholic Steatohepatitis Supplement Market with a 38.60% share in 2025, while Synbiotics is the fastest-growing type segment with a CAGR of 5.80% from 2026-2035.

• By Supplement Form, Capsule led the Non-Alcoholic Steatohepatitis Supplement Market with a 42.60% share in 2025, while Powder is the fastest-growing supplement form segment with a CAGR of 6.20% from 2026-2035.

• By Nutrition, Vitamin E led the Non-Alcoholic Steatohepatitis Supplement Market with a 34.60% share in 2025, while Milk Thistle is the fastest-growing nutrition segment with a CAGR of 6.60% from 2026-2035.

By Type, Probiotics Dominate the Non-Alcoholic Steatohepatitis Supplement Market While Synbiotics Register the Fastest Growth

Probiotics led the Non-Alcoholic Steatohepatitis Supplement Market because of growing recognition of the gut-liver axis and the role of balanced gut microbiota in supporting metabolic and liver health. Their established presence in dietary supplements, broad consumer awareness, and availability across multiple formulations contribute to strong adoption. Probiotics are also increasingly incorporated into products targeting digestive wellness alongside liver support. Rising interest in preventive nutrition and microbiome-focused health solutions further strengthens their demand among consumers seeking comprehensive approaches to liver wellness.

Synbiotics are the fastest-growing type segment because they combine probiotics and prebiotics to provide complementary microbiome-supporting benefits. Growing research into interactions between intestinal health, metabolism, and liver function is increasing interest in these combined formulations. Synbiotics can support more comprehensive digestive and metabolic wellness positioning, making them attractive to supplement manufacturers. Increasing consumer awareness of microbiome health, product innovation, and the availability of multifunctional formulations are encouraging adoption. Their ability to address multiple wellness needs supports sustained growth during the forecast period.

By Supplement Form, Capsules Dominate the Non-Alcoholic Steatohepatitis Supplement Market While Powder Emerges as the Fastest-Growing Form

Capsules led the Non-Alcoholic Steatohepatitis Supplement Market because they provide convenient administration, consistent dosing, and easy portability for consumers following daily supplementation routines. Their ability to deliver concentrated quantities of botanical extracts, vitamins, probiotics, and other nutritional ingredients in standardized formats supports widespread use. Capsules also help minimize unpleasant tastes and odors associated with certain active ingredients. Strong availability across pharmacies, specialty retailers, and e-commerce platforms further improves accessibility, while established manufacturing processes and consumer familiarity reinforce their leading position.

Powder is the fastest-growing supplement form because it offers flexible consumption and can be easily mixed with water, smoothies, functional beverages, or other foods. This format is particularly attractive to consumers seeking convenient alternatives to swallowing capsules or tablets. Powders can accommodate combinations of probiotics, prebiotics, botanical extracts, vitamins, and other nutritional ingredients, supporting multifunctional formulations. Rising interest in personalized nutrition, convenient wellness products, and innovative flavored formulations is encouraging manufacturers to expand powder-based offerings, supporting stronger adoption during the forecast period.

By Nutrition, Vitamin E Dominates the Non-Alcoholic Steatohepatitis Supplement Market While Milk Thistle Experiences the Fastest Growth

Vitamin E led the Non-Alcoholic Steatohepatitis Supplement Market because of its established role as an antioxidant and longstanding recognition in liver-focused nutritional supplementation. Its ability to be incorporated into standardized formulations makes it attractive to manufacturers developing products targeting oxidative stress and overall liver wellness. Strong consumer familiarity, extensive availability through supplement retailers and online channels, and its inclusion in various combination formulations support continued demand. Growing awareness of antioxidant nutrition and preventive health further reinforces Vitamin E's leading position within the market.

Milk Thistle is the fastest-growing nutrition segment because of increasing consumer interest in botanical ingredients for liver wellness and natural approaches to supplementation. Its long-standing traditional use and recognition as a liver-supporting botanical contribute to growing acceptance among health-conscious consumers. Standardized silymarin-based extracts also enable manufacturers to develop consistent and convenient formulations across capsules, powders, and combination supplements. Rising demand for plant-based wellness ingredients, expanding product availability, and increased interest in preventive liver health are expected to accelerate Milk Thistle adoption.

Regional Analysis:

Asia Pacific Non-Alcoholic Steatohepatitis Supplement Market Insights

Asia Pacific held the largest regional share of the Non-Alcoholic Steatohepatitis Supplement Market in 2025, driven by rising prevalence of obesity, rising NASH incidence, and increased product launches across the region. In many Asian countries, including South Korea, obesity and non-alcoholic fatty liver disease continue to rise in tandem, with individuals experiencing obesity or diabetes mellitus possessing higher NAFLD prevalence than the general population, reinforcing regional demand for supplement-based management.

China accounted for approximately 36.60% of the Asia Pacific market in 2025, supported by its large NAFLD-affected population and expanding domestic dietary supplement manufacturing and retail infrastructure. India, Japan, and South Korea are also contributing meaningfully to regional growth, with South Korea's rising obesity epidemic reinforcing sustained NASH supplement demand across the country's healthcare and retail systems.

Get Customized Report as Per Your Business Requirement - Enquiry Now

North America Non-Alcoholic Steatohepatitis Supplement Market Insights

North America is growing as a market for NASH supplements as people become more aware of the possible health advantages of supplements and turn to them to maintain health and avoid disease. According to the American Liver Foundation, NAFLD is the most frequent chronic liver ailment in the United States, with NASH affecting a meaningful share of adults, reinforcing sustained regional supplement demand.

The United States accounted for approximately 84.60% of the North American market in 2025, reflecting its large NAFLD-affected population and extensive dietary supplement retail infrastructure. Canada and Mexico are also contributing to regional growth through steady consumer wellness supplement adoption and growing awareness of liver health management options.

Europe Non-Alcoholic Steatohepatitis Supplement Market Insights

Europe is expected to expand as a market for NASH supplements, with NASH affecting 10 million people, or 18% of the European population, and its prevalence anticipated to rise by more than 40% by 2030. Consumers across the region continue becoming more aware of the possible health advantages of supplements, with many turning to supplementation to manage their health and avoid disease progression.

Germany led the European market with a 24.80% regional share in 2025, supported by its strong domestic dietary supplement manufacturing base and rising NASH awareness following EU-level advocacy initiatives. France, the United Kingdom, and Italy are also contributing meaningfully to regional growth, supported by expanding retail distribution of liver-support supplement products across major Western European markets.

Middle East & Africa and Latin America Non-Alcoholic Steatohepatitis Supplement Market Insights

The Middle East & Africa region is exhibiting steady growth as obesity and metabolic syndrome prevalence continue rising across the Gulf states, supported by growing modern retail infrastructure. Latin America is similarly benefiting from expanding consumer wellness supplement adoption and growing awareness of liver health management across major regional economies.

Saudi Arabia led the Middle East & Africa market with a 22.60% regional share in 2025, supported by rising obesity-related liver disease awareness and expanding modern retail penetration. Brazil represented 26.40% of the Latin American market in 2025, driven by expanding dietary supplement consumption, with Argentina and Colombia also contributing to regional growth through rising consumer health awareness.

Market Dynamics:

Growth Drivers: Rising NASH Awareness and Supplement Education Driving Market Growth

The Non-Alcoholic Steatohepatitis Supplement Market is being driven primarily by increasing initiatives to promote awareness of NASH, as the market for NASH supplements remains in its early stages with many consumers still unaware of the possible benefits of taking supplements. NASH and its symptoms are made more widely known through public education programs that also offer information on available treatments, such as NASH supplements, with growing awareness among patients and healthcare professionals encouraging usage in the management of NASH and related metabolic disorders.

Growing initiatives to promote awareness of NASH continue to encourage patients and healthcare professionals toward supplement-based management approaches. Rising research and development investment into NASH-related nutrition is uncovering new candidate ingredients, with research discovering that folate and vitamin B12 could help reduce scarring and inflammation in human patients and animal models. Expanding product launches featuring non-GMO, allergen-free supplement formulations are further addressing growing consumer preference for clean-label liver support products.

Restraints: Side Effects and Limited Consumer Awareness Limiting Market Expansion

Despite favorable underlying demand, the market faces meaningful restraints related to potential side effects or interference with other medications, as high doses of vitamin E supplements may increase bleeding risk in individuals on blood thinners, while omega-3 fatty acid supplements might interact with certain cholesterol-reducing drugs. Supplement safety and efficacy may vary depending on each patient's medical condition and other medications, complicating universal recommendation guidance.

Lack of awareness of potential benefits of NASH supplements continues to constrain broader market penetration, as many consumers remain unfamiliar with available supplement-based management options. The high cost of some NASH supplements, attributed to manufacturing expenses and the high cost of developing and testing novel formulations, also continues to limit accessibility for consumers already burdened by other medical expenses, particularly given the extended treatment durations typically required.

Opportunities: Novel Ingredient Research and Emerging Market Education Creating New Growth Avenues

Substantial opportunity exists in continued research and development investment into NASH-related nutrition, as future research investigating the underlying causes of NASH may help identify supplement ingredients capable of reversing underlying disease mechanisms rather than solely managing symptoms. Companies that successfully commercialize clinically validated novel ingredient combinations stand to capture significant share of category growth as scientific understanding of NASH pathophysiology continues advancing.

Growing consumer health awareness across emerging markets in Asia Pacific and Latin America represents a further significant growth avenue, as rising obesity and metabolic syndrome prevalence create new addressable populations for supplement-based liver health management. Expanding public education programs and physician engagement initiatives also represent meaningful untapped opportunity for manufacturers seeking to convert growing NASH awareness into sustained supplement adoption.

Recent Developments:

• 2026: DSM-Firmenich advanced its vitamin transformation initiative, integrating precision fermentation technologies to improve production efficiency for nutrition ingredients relevant to liver health formulations.

• 2023: Nestlé introduced Nature's Bounty in the Philippines, a line of five non-GMO supplements with no artificial flavors, colors, or sweeteners, expanding accessible liver-support supplement options.

• 2023: Intercept Pharmaceuticals announced a restructuring to improve focus on rare and critical liver disorders while discontinuing NASH-related pharmaceutical funding, reinforcing continued reliance on supplement-based management.

• 2023: OmniActive Health Technologies launched its 'Lutein for Every Age' campaign to enhance awareness of macular carotenoids in eye health, reflecting broader industry investment in ingredient-specific consumer education.

Non-Alcoholic Steatohepatitis Supplement Market key players are:

• Himalaya Wellness Company

• Amway Corporation (Nutrilite)

• Nature’s Bounty (Nestlé Health Science)

• NOW Foods

• Jarrow Formulas, Inc.

• Gaia Herbs

• Life Extension

• Swisse Wellness

• Nature’s Way

• GNC Holdings, LLC

• Integria Healthcare

• Irwin Naturals

• Solgar

• Pure Encapsulations

• Blackmores

• Herbalife Ltd.

• Pharmavite LLC (Nature Made)

• Garden of Life

• Enzymedica

• Dabur India Ltd.

Non-Alcoholic Steatohepatitis Supplement Market Report Scope: